Biomarker Analysis Services for Clinical Trials
Biomarker testing identifies molecular indicators of disease, helps stratify patients by predicting treatment responses, and improves selection of participants most likely to benefit. It also monitors biomarker levels to gauge treatment efficacy, provides early signs of success, and flags markers linked to adverse effects to support patient safety.
Biomarker Analysis Services for Clinical Trials
Biomarker testing identifies molecular indicators of disease, helps stratify patients by predicting treatment responses, and improves selection of participants most likely to benefit. It also monitors biomarker levels to gauge treatment efficacy, provides early signs of success, and flags markers linked to adverse effects to support patient safety.
Our Expertise
At Avance Biosciences, we deliver fit‑for‑purpose biomarker analysis for clinical trials across gene expression, genotyping, protein analysis, metabolomics, epigenetics, immunoassays, cytogenetics, flow‑based phenotyping, and microbiome profiling. These platforms translate samples into actionable decisions, from patient stratification and PD response tracking to safety monitoring. (See the table below for methods such as RNA‑seq, ddPCR, ELISA/MSD, LC‑MS/MS, 16S, and metagenomics.)
Biomarker Analysis Services for Clinical Trials
Service
Purpose
Technology
Gene Expression
Predict treatment outcomes, monitor treatment efficacy, and understand disease pathways.
Stratify patients based on genetic profiles and predict their responses to therapies.
- Amplicon NGS
- TaqMan assays
- End-point PCR
Protein Analysis
Identifies biomarkers for monitoring treatment efficacy.
Metabolomics
Provides insights into metabolic pathways and identifies biomarkers related to disease and treatment response.
Epigenetic Analysis
Identifies biomarkers that influence gene expression and disease outcomes.
- Bisulfite sequencing
- Methylation-specific PCR
Immunoassays
Identifies biomarkers in immunotherapy and infectious diseases.
Phenotyping
Identify and classify cell types and assess cellular responses to treatments.
Microbiomes Analysis
Identifies microbiome-related biomarkers that can impact health and treatment outcomes.
